Alamar Biosciences, Inc.

ALMR

Precision medicineBiotech & pharmaceuticalsHealthcare diagnostics

$33.97vs prev close▼-0.27(-0.79%)

$18.8552W Range$38.54

77% from low

+8.36 (+32.30%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

No trades in 1M

1M net buy

≈ 0 shares

Portfolio Weight

0.22%

1M +0.07%p

Holding ETFs

1 ETFs

ARKG

Buy · Weight Up

ARK net-bought the stock and the price rose, increasing its portfolio weight.

Shares +18.8% · Market value +31.2% · Weight +0.07%p

Trade Intensity

No trades in 1M

Trade Log

Date	Action	ETF	Shares	Close	Est. total
26.07.16	BUY	ARKG	37,822	$24.95	$943.7K
26.07.15	BUY	ARKG	29,223	$26.13	$763.6K
26.07.14	BUY	ARKG	10,424	$27.05	$282.0K
26.07.13	BUY	ARKG	37,003	$27.40	$1.0M
26.07.10	BUY	ARKG	1,991	$28.42	$56.6K
26.07.09	BUY	ARKG	676	$26.48	$17.9K
26.07.08	BUY	ARKG	20,644	$25.30	$522.3K
26.07.07	BUY	ARKG	18,183	$25.23	$458.8K
26.07.06	BUY	ARKG	37,947	$25.66	$973.7K
26.07.02	BUY	ARKG	12,996	$25.94	$337.1K
26.07.01	BUY	ARKG	83,891	$26.13	$2.2M
26.06.30	BUY	ARKG	18,829	$27.09	$510.1K
26.06.29	BUY	ARKG	2,390	$27.77	$66.4K
26.06.26	BUY	ARKG	9,476	$26.67	$252.7K
26.06.25	BUY	ARKG	478	$26.87	$12.8K

07.16BUY

37,822

ARKGClose$24.95Est. total$943.7K

07.15BUY

29,223

ARKGClose$26.13Est. total$763.6K

07.14BUY

10,424

ARKGClose$27.05Est. total$282.0K

07.13BUY

37,003

ARKGClose$27.40Est. total$1.0M

07.10BUY

1,991

ARKGClose$28.42Est. total$56.6K

07.09BUY

676

ARKGClose$26.48Est. total$17.9K

07.08BUY

20,644

ARKGClose$25.30Est. total$522.3K

07.07BUY

18,183

ARKGClose$25.23Est. total$458.8K

07.06BUY

37,947

ARKGClose$25.66Est. total$973.7K

07.02BUY

12,996

ARKGClose$25.94Est. total$337.1K

07.01BUY

83,891

ARKGClose$26.13Est. total$2.2M

06.30BUY

18,829

ARKGClose$27.09Est. total$510.1K

06.29BUY

2,390

ARKGClose$27.77Est. total$66.4K

06.26BUY

9,476

ARKGClose$26.67Est. total$252.7K

06.25BUY

478

ARKGClose$26.87Est. total$12.8K

1 / 2

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

954,806

Portfolio Weight

0.22%

in ETF 1.63%

Est. Value

$27M

30D Net

+$4M

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Buy

Strong Buy

Buy

Hold

Analyst Targets

avg.

$33.40

vs Current ▼ -2.5% downside

Current$34.24

Low ~ High$31.00 ~ $35.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Stifel

Buy

$32.00

-6.54%

—

Maintain

2026-08-11

JP Morgan

Overweight

$35.00

+2.22%

—

Maintain

2026-08-11

Leerink Partners

Outperform

$35.00

+2.22%

—

Upgrade

2026-05-12

TD Cowen

Buy

$30.00

-12.38%

—

Upgrade

2026-05-12

JP Morgan

Overweight

$30.00

-12.38%

—

Upgrade

2026-05-12

1 / 2

Avg Target

$33.40

vs Current ▼ -2.5% downside

Buy

5 analysts

Strong Buy 1Buy 3Hold 1

Low $31.00

Current $34.24

High $35.00

Firm	Position	Target	Upside	Close	Action	Date
Stifel	Buy	$32.00	-6.54%	—	Maintain	26.08.11
JP Morgan	Overweight	$35.00	+2.22%	—	Maintain	26.08.11
Leerink Partners	Outperform	$35.00	+2.22%	—	Upgrade	26.05.12
TD Cowen	Buy	$30.00	-12.38%	—	Upgrade	26.05.12
JP Morgan	Overweight	$30.00	-12.38%	—	Upgrade	26.05.12

1 / 2

Price Information

Previous Close$34.64

Open$34.93

Day Range$34.14 - $36.10

52-Week Range$18.85 - $38.54

1-Year Change55.64%

Trading Volume

Volume212,395

Avg Volume (3mo)320,727

Valuation

Market Cap2.4B

Book Value$4.51

Shares Outstanding69,392,766

Financials

Revenue (TTM)100.4M

Net Income-49,661,000

EPS$-0.72

EBITDA-37,483,000

Profitability

P/E Ratio-

P/B Ratio7.59

Return on Equity (ROE)-

Return on Assets (ROA)-

Profit Margin-49.45%

EV/EBITDA-58.09

Beta-

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)67.43

Company Overview

Alamar Biosciences is a proteomics company specializing in high-sensitivity protein biomarker analysis for research and early disease detection. Their core offerings include the NULISA platform for ultra-sensitive biomarker detection and the ARGO HT system for high-throughput biomarker profiling, supported by cloud-based analytics and specialized assays for neurodegenerative diseases. Alamar serves academic and industry researchers with its advanced proteomics solutions.

P/B

7.59

High valuation

ROE

Return on Equity

Beta

Market Volatility

RSI(14)

67.4

Neutral zone

AI-generated summary. Not investment advice.

Alamar Biosciences, Inc.

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks